1. Home
  2. NXPL vs RLYB Comparison

NXPL vs RLYB Comparison

Compare NXPL & RLYB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXPL
  • RLYB
  • Stock Information
  • Founded
  • NXPL 1997
  • RLYB 2018
  • Country
  • NXPL United States
  • RLYB United States
  • Employees
  • NXPL N/A
  • RLYB N/A
  • Industry
  • NXPL Telecommunications Equipment
  • RLYB Biotechnology: Pharmaceutical Preparations
  • Sector
  • NXPL Telecommunications
  • RLYB Health Care
  • Exchange
  • NXPL Nasdaq
  • RLYB Nasdaq
  • Market Cap
  • NXPL 13.8M
  • RLYB 14.4M
  • IPO Year
  • NXPL N/A
  • RLYB 2021
  • Fundamental
  • Price
  • NXPL $0.70
  • RLYB $0.40
  • Analyst Decision
  • NXPL
  • RLYB Hold
  • Analyst Count
  • NXPL 0
  • RLYB 3
  • Target Price
  • NXPL N/A
  • RLYB $15.00
  • AVG Volume (30 Days)
  • NXPL 50.7K
  • RLYB 240.7K
  • Earning Date
  • NXPL 05-15-2025
  • RLYB 05-08-2025
  • Dividend Yield
  • NXPL N/A
  • RLYB N/A
  • EPS Growth
  • NXPL N/A
  • RLYB N/A
  • EPS
  • NXPL N/A
  • RLYB N/A
  • Revenue
  • NXPL $62,515,000.00
  • RLYB $848,000.00
  • Revenue This Year
  • NXPL N/A
  • RLYB N/A
  • Revenue Next Year
  • NXPL N/A
  • RLYB N/A
  • P/E Ratio
  • NXPL N/A
  • RLYB N/A
  • Revenue Growth
  • NXPL 19.36
  • RLYB N/A
  • 52 Week Low
  • NXPL $0.43
  • RLYB $0.22
  • 52 Week High
  • NXPL $2.30
  • RLYB $1.73
  • Technical
  • Relative Strength Index (RSI)
  • NXPL 60.78
  • RLYB 59.92
  • Support Level
  • NXPL $0.60
  • RLYB $0.27
  • Resistance Level
  • NXPL $0.71
  • RLYB $0.49
  • Average True Range (ATR)
  • NXPL 0.05
  • RLYB 0.06
  • MACD
  • NXPL 0.01
  • RLYB 0.01
  • Stochastic Oscillator
  • NXPL 93.27
  • RLYB 57.34

About NXPL NextPlat Corp

NextPlat Corp is an e-commerce and healthcare company. Its e-commerce venues form an effective network serving thousands of consumers, enterprises, and governments. Its healthcare business is focused on improving the lives of patients with complex chronic diseases through patient and provider engagement and their partnerships with payors, pharmaceutical manufacturers, and distributors, offering a broad range of solutions to address the dispensing, delivery, dosing, and reimbursement of clinically intensive, high-cost drugs. The company operates in two segments: e-Commerce Operations involves acquiring and leasing an e-commerce platform; and Healthcare Operations provides TPA, data management, COVID-19 related diagnostics and vaccinations, prescription pharmaceuticals, and Others.

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

Share on Social Networks: